The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer

Qu,Ying; Zhou,Chenfei; Zhang,Jianian; Cai,Qu; Li,Jianfang; Du,Tao; Zhu,Zhenggang; Cui,Xiaojiang; Liu,Bingya

doi:10.3892/ijo.2014.2328

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer

Authors:
- Ying Qu
- Chenfei Zhou
- Jianian Zhang
- Qu Cai
- Jianfang Li
- Tao Du
- Zhenggang Zhu
- Xiaojiang Cui
- Bingya Liu
View Affiliations

Affiliations: Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China, Department of Surgery, Department of Obstetrics and Gynecology, Women's Cancer Institute, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Published online on: March 6, 2014 https://doi.org/10.3892/ijo.2014.2328
Pages: 1512-1520

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

SOX11 is involved in gastrulation and in malignant diseases. The aim of this study was to investigate the role of SOX11 in gastric cancer and its expression pattern and clinical significance. SOX11 overexpression cell model was used to examine in vitro and in vivo the role of SOX11 in cell growth and metastasis. Cell cycle analysis and Annexin V/PI double staining were used to investigate the effect of SOX11 on cell cycle progression and apoptosis. The expression of SOX11 in human gastric cancer was examined by immunohistochemistry. The correlation of SOX11 expression with clinicopathological characteristics and survival of patients was analyzed by Pearson's χ2 and Kaplan-Meier analyses, respectively. Cox's proportional hazard model was employed in multivariate analysis. SOX11 overexpression did not inhibit cell growth but strongly suppressed cell migration/invasion in vitro and in vivo. We found a significant correlation between high SOX11 protein levels and Lauren's classification (intestinal type), differentiation status (high and medium), and early TNM stage. SOX11 is an independent prognostic factor for improved survival in gastric cancer patients. SOX11 was a potential tumor-suppressor and an independent positive prognostic factor in gastric cancer patients with less advanced clinicopathological features.

View Figures

View References

1.	Hohenberger P and Gretschel S: Gastric cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar
2.	Smith DD, Schwarz RR and Schwarz RE: Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 23:7114–7124. 2005. View Article : Google Scholar : PubMed/NCBI
3.	Dy P, Penzo-Mendez A, Wang H, Pedraza CE, Macklin WB and Lefebvre V: The three SoxC proteins - Sox4, Sox11 and Sox12 - exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 36:3101–3117. 2008. View Article : Google Scholar : PubMed/NCBI
4.	Sudbeck P and Scherer G: Two independent nuclear localization signals are present in the DNA-binding high-mobility group domains of SRY and SOX9. J Biol Chem. 272:27848–27852. 1997. View Article : Google Scholar : PubMed/NCBI
5.	Gasca S, Canizares J, De Santa Barbara P, et al: A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc Natl Acad Sci USA. 99:11199–11204. 2002. View Article : Google Scholar
6.	Rehberg S, Lischka P, Glaser G, Stamminger T, Wegner M and Rosorius O: Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol. 22:5826–5834. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Prior HM and Walter MA: SOX genes: architects of development. Mol Med. 2:405–412. 1996.PubMed/NCBI
8.	Hargrave M, Wright E, Kun J, Emery J, Cooper L and Koopman P: Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio-mesenchymal induction. Dev Dyn. 210:79–86. 1997. View Article : Google Scholar : PubMed/NCBI
9.	Sock E, Rettig SD, Enderich J, Bosl MR, Tamm ER and Wegner M: Gene targeting reveals a widespread role for the high-mobility-group transcription factor Sox11 in tissue remodeling. Mol Cell Biol. 24:6635–6644. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Gustavsson E, Sernbo S, Andersson E, et al: SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 9:1872010. View Article : Google Scholar : PubMed/NCBI
11.	Wang X, Asplund AC, Porwit A, et al: The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol. 143:248–252. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Mozos A, Royo C, Hartmann E, et al: SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 94:1555–1562. 2009. View Article : Google Scholar : PubMed/NCBI
13.	Brennan DJ, Ek S, Doyle E, et al: The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. Eur J Cancer. 45:1510–1517. 2009. View Article : Google Scholar : PubMed/NCBI
14.	Zeng W, Fu K, Quintanilla-Fend L, Lim M, Ondrejka S and Hsi ED: Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression. Am J Surg Pathol. 36:214–219. 2012. View Article : Google Scholar : PubMed/NCBI
15.	Safina A, Vandette E and Bakin AV: ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene. 26:2407–2422. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Cho JY, Lim JY, Cheong JH, et al: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
17.	Wang Q, Wen YG, Li DP, et al: Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 29:77–83. 2012. View Article : Google Scholar : PubMed/NCBI
18.	D’Errico M, de Rinaldis E, Blasi MF, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 45:461–469. 2009.PubMed/NCBI
19.	Ooi CH, Ivanova T and Wu J: Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
20.	Sernbo S, Gustavsson E, Brennan DJ, et al: The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer. 11:4052011. View Article : Google Scholar : PubMed/NCBI
21.	Delot EC, Bahamonde ME, Zhao M and Lyons KM: BMP signaling is required for septation of the outflow tract of the mammalian heart. Development. 130:209–220. 2003. View Article : Google Scholar : PubMed/NCBI